Form 8-K - Current report:
SEC Accession No. 0000950170-23-013165
Filing Date
2023-04-18
Accepted
2023-04-18 07:15:43
Documents
12
Period of Report
2023-04-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K clsd-20230418.htm   iXBRL 8-K 73793
  Complete submission text file 0000950170-23-013165.txt   192383

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsd-20230418_pre.xml EX-101.PRE 9843
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsd-20230418.xsd EX-101.SCH 2469
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsd-20230418_lab.xml EX-101.LAB 13360
6 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20230418_htm.xml XML 4717
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 23825488
SIC: 2834 Pharmaceutical Preparations